CLINICAL_TRIALS ClinicalTrials.gov record update

A Single-Arm Multi-Center Trial of Bendamustine Given With Ofatumumab (BendOfa) in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia (CLL). EudraCT Number 2009-017663-42. GIMEMA CLL0809 Protocol

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01244451
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:01.677815+00:00
Published At: 2019-01-25T00:00:00+00:00
Record Updated At: 2019-01-25
Results Posted At: 2019-01-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Patients With CLL Relapsing After an Initial Response (CR, PR \u2265 6 Months) Following no More Than Two Prior Treatment Lines; or", "Patients With CLL Refractory (SD, PD or CR/PR \u003c 6 Months) Following no More Than Two Prior Treatment Lines"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-01-25"
protocolSection.identificationModule.nctId: "NCT01244451"
protocolSection.identificationModule.officialTitle: "A Single-Arm Multi-Center Trial of Bendamustine Given With Ofatumumab (BendOfa) in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia (CLL). EudraCT Number 2009-017663-42. GIMEMA CLL0809 Protocol"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-01-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.